CMPS COMPASS Pathways plc Stock Quote

CMPS [NASD]

Healthcare | Medical Care Facilities | United Kingdom

Index	-	P/E	-	EPS (ttm)	-1.73	Insider Own	4.51%	Shs Outstand	35.93M	Perf Week	-6.12%
Market Cap	1.38B	Forward P/E	-	EPS next Y	-2.08	Insider Trans	0.00%	Shs Float	10.70M	Perf Month	-8.32%
Income	-60.30M	PEG	-	EPS next Q	-0.47	Inst Own	15.10%	Short Float	17.18%	Perf Quarter	-24.71%
Sales	-	P/S	-	EPS this Y	-186.40%	Inst Trans	5.31%	Short Ratio	3.91	Perf Half Y	-5.20%
Book/sh	5.47	P/B	6.23	EPS next Y	-14.30%	ROA	-	Target Price	-	Perf Year	-
Cash/sh	4.68	P/C	7.27	EPS next 5Y	-	ROE	-	52W Range	22.51 - 61.69	Perf YTD	-28.48%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-42.66%	Beta	-
Dividend %	-	Quick Ratio	29.40	Sales past 5Y	-	Gross Margin	-	52W Low	57.15%	ATR	2.28
Employees	61	Current Ratio	29.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	47.33	Volatility	5.31% 6.16%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-178.00%	Profit Margin	-	Rel Volume	1.34	Prev Close	34.07
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Mar 09 BMO	Payout	-	Avg Volume	470.69K	Price	35.38
Recom	1.80	SMA20	-0.46%	SMA50	-6.92%	SMA200	-15.01%	Volume	574,331	Change	3.83%

Apr-01-21

Initiated

ROTH Capital

Buy

$88

Oct-14-20

Initiated

H.C. Wainwright

Buy

$65

Oct-13-20

Initiated

Evercore ISI

Outperform

Oct-13-20

Initiated

Cowen

Outperform

Oct-13-20

Initiated

Canaccord Genuity

Buy

$80

Oct-13-20

Initiated

Berenberg

Buy

$50

May-06-21 08:00AM	COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021 GlobeNewswire
May-03-21 03:01PM	Robinhood is a misunderstood platform: Kevin O'Leary Yahoo Finance Video
Apr-29-21 08:45PM	COMPASS Pathways announces pricing of public offering GlobeNewswire +8.46%
08:23AM	Zacks Industry Outlook Highlights: Avantor, Eurofins Scientific, GoodRx Holdings, Apollo Medical and COMPASS Pathways Zacks
Apr-28-21 09:23AM	5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges Zacks -7.90%
06:43AM	Psychedelic drugmaker MindMed stumbles in Nasdaq debut, CEO says 'still very early innings' Yahoo Finance
Apr-27-21 05:22PM	COMPASS Pathways launches proposed public offering GlobeNewswire
04:43PM	MindMed Stock Reverses In Nasdaq Debut As Psychedelics Follow Pot's Path To Mainstream Investor's Business Daily
02:41PM	MindMed CEO on going public: This is about how to allocate capital to mental health Yahoo Finance Video
Apr-21-21 04:01PM	Psychedelic Stocks: Atai Life Sciences IPO Seeks To Raise $100 Million Investor's Business Daily
Apr-15-21 07:49AM	The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split Benzinga -5.34%
03:00AM	New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder GlobeNewswire
Apr-09-21 07:00AM	COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference GlobeNewswire
Apr-01-21 07:01AM	COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors GlobeNewswire
Mar-26-21 01:49PM	Psyched: Compass' New Patents, Cure Extends DEA License, Andrew Yang Supports Psilocybin in NYC Benzinga
11:56AM	Numinus Wellness May Be the Best Penny Stock to Buy Today InvestorPlace
Mar-23-21 08:00AM	COMPASS Pathways granted two US patents GlobeNewswire
Mar-18-21 02:36AM	We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely Simply Wall St. -6.90%
Mar-15-21 12:40PM	Psyched: The Patents Dilemma, Compass 2020 Earnings, New Psilocybin Bill In NY Benzinga
Mar-12-21 11:43AM	7 Healthcare Stocks to Buy and Hold for the Long Term InvestorPlace
Mar-09-21 07:00PM	COMPASS Pathways plc (CMPS) Q4 2020 Earnings Call Transcript Motley Fool +12.00%
07:00AM	COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020 GlobeNewswire
05:15AM	Compass Pathways Plc - ADR to Host Earnings Call ACCESSWIRE
Mar-03-21 07:20AM	3 Outside-the-Box Stocks to Buy Now Motley Fool
Mar-02-21 07:00AM	COMPASS Pathways plc to announce fourth quarter and full year 2020 financial results on 9 March 2021 GlobeNewswire
Feb-27-21 06:50AM	Investing $1,000 in These 2 Psychedelic Stocks Is an Absurdly Smart Move Motley Fool
Feb-26-21 07:00AM	COMPASS Pathways plc to participate in Cowen's 41st Annual Health Care Conference GlobeNewswire -6.41%
Feb-25-21 08:30AM	Psychedelic Stocks Poised to Resume the Upward Trend GlobeNewswire
Feb-11-21 08:30AM	264 Million Reasons Psychedelic Stocks Have More Room to Grow GlobeNewswire +11.86%
Feb-09-21 07:02AM	COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists GlobeNewswire
Feb-03-21 07:00AM	COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy GlobeNewswire +6.74%
Jan-28-21 08:00AM	COMPASS Pathways plc to participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference GlobeNewswire
Jan-27-21 08:59AM	The world's first psychedelic ETF debuts Yahoo Finance
Jan-26-21 12:51PM	Psychedelics ETF to Launch After Sector Attracts Thiels Money Bloomberg
Jan-18-21 12:57PM	Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week Benzinga
Jan-16-21 09:38AM	Psyched: Compass Launches Center Of Excellence, Entheon Purchases HaluGen, Atai Buys Majority Stake In Recognify Benzinga
Jan-11-21 04:30PM	As the Focus on Psychedelic Stocks Increases, So Do the Valuations TheStreet.com
Jan-08-21 01:19PM	5 Groovy Psychedelic Stocks to Buy InvestorPlace
07:47AM	Correction: COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care GlobeNewswire
07:47AM	COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care GlobeNewswire
07:00AM	COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care GlobeNewswire
Jan-06-21 07:30AM	COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences GlobeNewswire +5.95%
Jan-04-21 08:00AM	Four Top Psychedelic Stock Picks for 2021 GlobeNewswire -8.48%
Dec-28-20 09:02AM	2020 Was The Year of Psychedelics Here's Why Benzinga
Dec-26-20 08:04AM	Is Compass Pathways Stock a Buy? Motley Fool
Dec-21-20 08:00AM	The Next Leg in the Bull Market for Psychedelic Stocks GlobeNewswire
Dec-18-20 12:27AM	Is COMPASS Pathways plc (NASDAQ:CMPS) Popular Amongst Insiders? Simply Wall St.
Dec-16-20 03:19PM	Is CMPS A Good Stock To Buy Now? Insider Monkey
Nov-25-20 03:08PM	Snowflake On Fire: Are These IPO Stocks Ready To Buy? Investor's Business Daily +9.46%
Nov-24-20 08:30AM	Another Bet on Psychedelic Drugs: Atai Raises $125 Million Barrons.com
Nov-23-20 06:48PM	Psychedelic Drug Stock's Biggest Investor Closes $125 Million Funding Round Investor's Business Daily +5.62%
Nov-15-20 08:26AM	The psychedelic drug industry is 'the new cannabis' for investors Yahoo Finance
Nov-12-20 04:03PM	Psychedelic Drug IPO Explains Why It's Cautious On Oregon's Legalization Investor's Business Daily
07:02AM	COMPASS Pathways plc announces financial results for third quarter 2020 GlobeNewswire
Nov-10-20 01:15PM	25 States that have the Highest Rates of Depression in America Insider Monkey
Nov-09-20 09:50AM	A Handful of Start-Ups Is Developing Psychedelic Drugs for Mental Illnesses. It Could Be a Bad Trip for Investors. Barrons.com
07:00AM	COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care GlobeNewswire
Nov-05-20 07:00AM	COMPASS Pathways plc to announce third quarter 2020 financial results on 12 November 2020 GlobeNewswire +10.88%
Nov-04-20 04:17PM	Psychedelic Drug Stock Jumps After State Ballot Legalizes Therapy Investor's Business Daily +8.94%
09:20AM	COMPASS Pathways plc to participate in Berenberg and Evercore investor conferences GlobeNewswire
Oct-26-20 07:00AM	COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO GlobeNewswire -7.01%
Oct-16-20 02:55AM	UPDATE - Trends in Psychedelic Drugs Research and Four Stocks You Should Know About GlobeNewswire
Sep-22-20 04:03PM	COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters option to purchase additional American Depositary Shares GlobeNewswire +33.16%
Sep-18-20 04:19PM	First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO Investor's Business Daily
12:33PM	Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price MarketWatch
Sep-17-20 10:40PM	COMPASS Pathways announces pricing of upsized initial public offering GlobeNewswire

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience